Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women with Early-stage Uterine Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 40, Issue 2, 2017, Pages 183-188

  Elshaikh, Mohamed A ^a   Vance, Sean ^a   Kamal, Mona ^a   Burmeister, Charlotte ^a   Hanna, Rabbie K ^a   Rasool, Nabila ^a   Siddiqui, Farzan ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Charlson comorbidity index; comorbidity; mortality; prognosis; survival; uterine cancer

Indexed keywords

ADULT; AGE; AGED; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PHYSICIAN; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; UTERUS CANCER; VERY ELDERLY; COMPLICATION; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 84913582102     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0000000000000129     Document Type: Conference Paper

References (29)

1. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
3. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92: 744-751.
4. Nicholas Z, Hu N, Ying J, et al. Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol. 2014;37:131-134.
5. Ward KK, Shah NR, Saenz CC, et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126:176-179.
6. Truong PT, Kader HA, Lacy B, et al. The effects of age and comorbidity on treatment and outcomes in women with endome-trial cancer. Am J Clin Oncol. 2005;28:157-164.
7. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
8. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
9. Sperling C, Noer MC, Christensen IJ, et al. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database. Gynecol Oncol. 2013;129:97-102.
10. Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112:2384-2392.
11. Ouellette JR, Small DG, Termuhlen PM. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg. 2004;8:-1061-1067.
12. Kopek N, Paludan M, Petersen J, et al. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer. Radiother Oncol. 2009;93:402-407.
13. Robbins JR, Gayar OH, Zaki M, et al. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early stage endometrial cancer. Gynecologic Oncol. 2013;131:593-597.
14. Gayar OH, Patel S, Schultz D, et al. The impact of tumor grade on survival endpoints and patterns of recurrence of 949 patients with early stage endometrioid carcinoma. a single institution study. Int J Gynecolo Cancer. 2013;131:593-597.
15. Zaki MA, Robbins JR, Fatteh S, et al. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement. Anticancer Res. 2012;32:4061-4066.
16. Gayar OH, Robbins JR, Parikh K, et al. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gynecol Oncol. 2011;123:71-75.
17. Vance S, Yechieli R, Cogan C, et al. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Gynecol Oncol. 2012;126:16-19.
18. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816-823.
19. The ASTEC/EN.5 writing committee on behalf of the ASTEC/ EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.
20. Scholten AN, van Putte WLJ, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of randomized PORTEC trial with central pathology review. Int J Radiation Oncology Biol Phys. 2005;63:834-838.
21. Robbins JR, Yechieli R, Laser B, et al. Is time to recurrence after hysterectomy predictive of survival for patients with initial early stage endometrial carcinoma? Gynecologic Oncol. 2012;127: 38-42.
22. Elshaikh MA, Vance S, Suri JS, et al. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk, early stage endometrial carcinoma. Int J Radiati Oncol Biol Physics. 2014;88:351-356.
23. Yechieli R, Rasool N, Robbins JR, et al. The impact of adjuvant radiation therapy on tumor recurrence and survival of surgically staged patients with type ii endometrial carcinoma. A single institution experience. Int J Gynecol Cancer. 2013;23:763-768.
24. Ly D, Rowley BD, Dodson MK, et al. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival. Gynecol Oncol. 2014; 133:250-255.
25. Cattaneo R II, Hanna RK, Jacobsen G, et al. Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma: A single institution experience. Int J Radiat Oncol Biol Physics. 2014; 88:866-871.
26. Folsom AR, Anderson KE, Sweeney C, et al. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 2004;94:740-745.
27. Olson SH, Atoria CL, Cote ML, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2012;21:753-760.
28. Cook LS, Nelson HE, Cockburn M, et al. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control. 2013;24:61-69.
29. Kieszak SM, Flanders WD, Kosinski AS, et al. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999;52: 137-142.